Cybin’s CYB004-E Phase 1 trial evaluating DMT has completed dosing for four out of five participant cohorts.
The European Psychiatric Association (EPA) is joining the Psychedelic Access and Research European Alliance (PAREA) as a full member.
Psyence Group has completed an export of psilocybin to Psilo Pharma from its federally licensed ISO22000 certified production facility in Southern Africa, through its research partner...
Psychedelic Health speaks to the founder of the Psychedelic Access and Research European Alliance (PAREA), Tadeusz Hawrot, about how the organisation aims to facilitate discussions around...
Clerkenwell Health is expanding its pan-European advisory board with the addition of Dr David Erritzoe, Dr Dea Siggaard Stenbæk, Dr Kim Kuypers and Dr James Stone...
Last week Italy’s Constitutional Court blocked the country’s campaign calling for the decriminalisation of psychotropic substance cultivation.
Launching its first European therapy centre in the Netherlands in early 2021, Field Trip Health is providing psychedelic healing experiences using truffles.
Leafy Tunnel’s USD$30m (~£22.38m) fund focuses on global psychedelics opportunities alongside European medical cannabis opportunities.
Signatures for an Italian campaign calling for the decriminalisation of psychotropic substance cultivation have now been verified by officials.
Levitee Labs has announced it has listed on the Frankfurt Stock Exchange (FSE).